Grade 1 Fatty Liver on Your Ultrasound? These Blood Tests Track What Happens Next

What the scan sees versus what the blood tests see

An ultrasound finds fatty liver because fat changes how sound waves bounce off the liver. The radiologist grades it by how bright the liver looks compared to the kidney and whether the blood vessel walls and diaphragm stay visible: Grade 1 is a mild brightness increase with everything still visible, Grade 2 is a moderate increase with the vessels getting fuzzy, Grade 3 is a severe increase where you can barely see through it. That grade describes how the liver looks, not how damaged it is. A Grade 1 scan cannot tell you whether you have simple fat or early inflammation.

Blood tests, on the other hand, cannot see fat at all. They measure what leaks out of injured liver cells (the enzymes ALT and AST), how well the liver handles waste (bilirubin), what it manufactures (albumin, proteins), and how it manages fats and sugar (triglycerides, cholesterol, glucose, HbA1c). Think of it this way: the scan takes a photograph of the fat, the blood work reads the liver's diary. You need both, and each can be normal while the other is not.

That is also why a fatty liver workup is never one test. At our lab in Malad, we see the same pattern every week: a patient books a single SGPT because someone told them "your liver number is high," and the doctor then asks for the rest of the panel, the lipids, and the sugar. Start with the full picture and you save yourself a second needle prick.

SGPT (ALT): the number everyone circles in red

SGPT, also written as ALT (alanine aminotransferase), is the enzyme most people mean when they say "my liver number." It lives mostly inside liver cells. When those cells are irritated or injured, ALT leaks into the blood, so a raised ALT is the most liver-specific signal on a standard report.

The typical laboratory reference range is 7–56 U/L, though some labs print 4–36 or 0–45 U/L. Here is the catch that even many doctors gloss over: lab reference ranges were built from general populations that include a lot of undiagnosed fatty liver. Hepatologists argue the truly healthy upper limit is much lower, roughly 19 U/L for women and 30 U/L for men. So an ALT of 48 can be stamped "normal" on your printout while still being worth a conversation with your doctor, especially if you carry belly fat or have borderline sugar.

In MASLD, ALT elevation is usually mild, about 1.5 to 3 times the upper limit, and rarely shoots past 300 IU/L even when the disease is real. That mildness is exactly why people dismiss it. "Only slightly raised" is the single most common phrase on reports that later turn out to matter.

One more lab truth: the size of the ALT bump does not predict the size of the problem. A modest ALT can sit alongside real fibrosis, and a big ALT spike can come from something as ordinary as a heavy workout the day before, a chest infection, or a medicine your liver dislikes. The number opens the question; it never answers it alone. If you want the single most useful test link to keep, it is the SGPT (ALT) test, because everything else in this guide refers back to it.

SGOT (AST) and the ratio doctors read

SGOT, or AST (aspartate aminotransferase), is ALT's sibling. It also leaks from injured liver cells, but it is less liver-specific: AST lives in heart muscle, skeletal muscle, kidneys, and red blood cells too. That is why doctors read AST next to ALT rather than on its own. The typical range is about 8–33 U/L.

The interesting part is the ratio. In MASLD, the AST:ALT ratio usually sits below 1, meaning ALT is higher than AST. When the ratio flips and climbs above 1, it often means fibrosis is advancing and the liver's plumbing is changing. And when AST is more than double the ALT, alcohol-related liver injury becomes the leading suspect, because alcohol damages mitochondria, where AST hangs out. So the same two numbers tell three different stories depending on how they relate: ALT-led and mild is classic MASLD, a rising ratio whispers fibrosis, and AST-dominant points at alcohol. This is why you book them together, and why the SGOT (AST) test is always interpreted beside its sibling, never solo.

GGT, bilirubin, ALP: the supporting cast on your report

GGT (gamma-glutamyl transferase) is the enzyme that rises with bile-flow stress and, famously, with alcohol. It is sensitive but not specific: GGT climbs with alcohol use, certain medicines, obesity, and diabetes. Reference ranges vary more between labs than most enzymes, often somewhere between 0–30 and 8–61 IU/L, so always read your own lab's printed range. In a fatty liver workup, a high GGT nudges the doctor to ask honestly about alcohol, because that changes the diagnosis from MASLD toward alcohol-related disease or the MetALD overlap. The dedicated GGT test is the one to book if alcohol is part of your story.

Bilirubin is the liver's waste product, the yellow pigment from old red blood cells that a healthy liver clears into bile. Total bilirubin usually runs 0.1–1.2 mg/dL. Fatty liver by itself rarely pushes bilirubin up; a raised bilirubin, especially the direct fraction, means something is obstructing bile flow or the liver is struggling at a deeper level. That is why bilirubin matters as a negative finding in fatty liver: if it is normal, that is reassuring. Book the bilirubin total and direct test when you want the full waste-clearance picture.

ALP (alkaline phosphatase) is the odd one out: it rises with bile duct problems and bone activity, and in MASLD it usually stays normal. A markedly high ALP, more than three times the upper limit, is not a fatty liver feature at all and needs its own workup. Knowing which numbers should stay normal is as useful as knowing which ones rise.

Platelets and albumin: quiet clues about scarring

Platelets are not a liver test in most people's minds, but in fatty liver they are quietly one of the most informative numbers on the report. As fibrosis advances, the spleen enlarges and traps platelets, and the scarred liver makes less thrombopoietin, the hormone that tells the bone marrow to produce them. So a platelet count drifting down over the years, even while still inside the normal 1.5–4.5 lakh range, can be an early whisper of scarring. Platelets become one quarter of the FIB-4 score, which we will get to in a moment.

Albumin is the main protein your liver manufactures, and it is a slow-moving marker. Albumin has a long half-life in the blood, so it only falls when the liver has been underperforming for a while, which is why a low albumin suggests chronic, established disease rather than a fresh problem. A normal albumin in early fatty liver is expected and reassuring. The typical range is about 3.4–5.4 g/dL, though some labs print 4.0–6.0 g/dL, ranges vary by laboratory, as they do for nearly every liver value.

FIB-4: a fibrosis check built from numbers already on your report

Here is the part of fatty liver testing most people never hear about. FIB-4 is a free score that estimates your risk of advanced liver scarring using four values that are already on routine blood work: your age, AST, ALT, and platelet count. The formula is (age × AST) divided by (platelets × the square root of ALT). No new sample, no extra cost, no scan.

Diabetes and liver societies now recommend FIB-4 as the first-line fibrosis check for people with MASLD, type 2 diabetes, or metabolic syndrome. The cutoffs are simple: below 1.3 is low risk and reliably rules out advanced fibrosis, between 1.3 and 2.67 is a grey zone that calls for a FibroScan or elastography, and above 2.67 is high risk and deserves a liver specialist. If you are over 65, the low-risk bar moves to 2.0. People with diabetes or prediabetes, or two or more metabolic risk factors, are advised to have it checked every one to two years.

The practical takeaway: the next time you hold a report with AST, ALT, and a platelet count, you are holding three quarters of a fibrosis screen. Ask your doctor to calculate it. It takes thirty seconds and it is the single most underused number in fatty liver care.

A quick worked example makes it concrete. Take a 45-year-old with AST 38, ALT 52, and platelets 2.2 lakh (220 in the units the formula uses). Multiply age by AST: 45 × 38 = 1710. Take the square root of ALT, about 7.2, and multiply by platelets: 220 × 7.2 = 1584. Divide: 1710 / 1584 ≈ 1.08. That is below 1.3, low risk, which matches the story of mild enzyme elevation with healthy platelets. Change the inputs to a 58-year-old with AST 64, ALT 48, and platelets 1.3 lakh: 58 × 64 = 3712; √48 ≈ 6.9; 130 × 6.9 = 897; 3712 / 897 ≈ 4.1, firmly above 2.67, high risk, and that patient should see a liver specialist. Same two enzymes, wildly different meaning once age and platelets join the picture.

Notice what drove the difference. It was not the ALT, which was actually lower in the second case. It was the older age, the higher AST relative to ALT, and the falling platelets. That is the whole philosophy of fatty liver blood work in one calculation: no single number carries the diagnosis, the pattern does. It is also why a report with "everything normal" deserves a second look when the metabolic numbers are off. A 42-year-old with an ALT of 30, triglycerides of 240, an HbA1c of 6.3%, and a waistline that has grown two inches in three years has more liver risk on paper than a 42-year-old with an ALT of 55 and clean metabolic numbers, even though the first report looks prettier. Doctors call this risk stratification. You can just call it reading the whole report instead of one line.

The metabolic half: sugar, insulin, triglycerides

Fatty liver is a metabolic condition, so the tests that track its engine are metabolic ones. The big three:

HbA1c tells you your average blood sugar over the past two to three months. Below 5.7% is normal, 5.7–6.4% is prediabetes, and 6.5% or above is diabetes. It needs no fasting, which makes it the easiest metabolic test to add. Nearly half of people with type 2 diabetes have MASLD, and the overlap runs both ways, so the HbA1c test belongs in every fatty liver workup.

Fasting blood sugar is the morning snapshot: below 100 mg/dL is normal, 100–125 is prediabetes, 126 or above is diabetes, after an 8-hour overnight fast. It is cheaper and faster than HbA1c and catches day-to-day control.

The lipid profile is where fatty liver's fingerprint often shows up first: triglycerides at or above 150 mg/dL and HDL below 40 mg/dL in men or 50 mg/dL in women are two of the metabolic syndrome criteria that define MASLD. Total cholesterol and LDL matter for heart risk, but for the liver story, high triglycerides with low HDL is the classic pattern. Book the lipid profile after a proper 9–12 hour fast, which is this lab's protocol, and we will come back to preparation below.

Some doctors also calculate HOMA-IR from fasting insulin and fasting glucose as a window into insulin resistance, the engine underneath most fatty liver. A value above 2.5 is commonly taken as insulin-resistant, but be aware that no major guideline endorses HOMA-IR for routine use and it depends heavily on the insulin assay, so treat it as a conversation starter with your doctor, not a verdict.

Together, these metabolic numbers do something the liver enzymes cannot: they tell you why the fat is there and how aggressively to chase it. A person with Grade 1 fatty liver, an ALT of 44, an HbA1c of 6.1%, and triglycerides of 210 has a very different next year ahead of them than someone with the same scan and clean metabolic numbers.

FAQs: the questions patients actually ask

My SGPT (ALT) is 68. Is that serious? It is mildly elevated, roughly one and a half to two times the usual upper limit, and that is the single most common pattern in fatty liver. It is not an emergency by itself. It means the liver is irritated and deserves a proper follow-up: AST alongside it, a repeat test after a few weeks, and the metabolic workup (sugar, lipids) if that has not been done. One mildly high ALT is a nudge, not a diagnosis.

Can fatty liver reverse? Yes, especially early. Liver societies quote concrete numbers: losing 3–5% of body weight reduces liver fat, and 7–10% improves inflammation and even early fibrosis. Simple steatosis without inflammation is the most reversible stage. That is the whole point of catching it at Grade 1.

Do I need a CT scan, or is ultrasound enough? Ultrasound is the first-choice screening test and is enough for the diagnosis of fatty liver in most people. A CT adds radiation without adding useful information for routine fatty liver. When the question is fibrosis rather than fat, the next step is a FibroScan, which measures liver stiffness in kilopascals, not another CT. Liver biopsy remains the only way to definitively diagnose MASH, but it is reserved for unclear or advanced cases.

Does alcohol show up differently from non-alcoholic fatty liver in blood tests? Often, yes. MASLD typically shows ALT higher than AST (ratio below 1). Alcohol-related injury tends to flip that, with AST more than double the ALT, and GGT usually climbs with regular drinking. But the two overlap in real life, which is why doctors ask about drinking directly and why the newer MetALD category exists for people with both.

How often should I retest? There is no single schedule, but the sensible rhythm is: repeat liver enzymes a few months after lifestyle changes to see the trend, and get a FIB-4 every one to two years if you have diabetes, prediabetes, or two or more metabolic risk factors. Do not retest the morning after drinking or a brutal workout; you will be measuring the weekend, not your liver.

My LFT is normal but the ultrasound shows fatty liver. Which do I believe? Both. The scan sees fat, the blood test sees injury, and fat without injury is exactly what early MASLD looks like. Studies find up to half to three-quarters of people with fatty liver have normal enzymes at any given time. A normal LFT with a fatty scan is not a contradiction and not a reason to ignore the scan; it is a reason to check the metabolic numbers and recheck the liver numbers later.

What is FIB-4 and can my lab calculate it? It is a fibrosis risk score built from your age, AST, ALT, and platelet count, all routine values. Below 1.3 is low risk, 1.3–2.67 needs a FibroScan to clarify, above 2.67 warrants a liver specialist. Any lab's numbers feed it, and any doctor can calculate it in under a minute. If nobody has ever calculated yours, ask.

Does a high SGPT mean I have hepatitis? No. In adults with metabolic risk factors, fatty liver is the most common cause of a mildly raised ALT. Viral hepatitis needs its own specific tests (hepatitis B and C markers), and your doctor orders those when the pattern or your history suggests them. A lone mild ALT bump is far more likely to be metabolic than viral.

Can medicines cause fatty liver on my report? Some long-term medicines can encourage fat buildup in the liver, including certain heart-rhythm drugs, some cancer and autoimmune treatments, steroids, and some hormone therapies. This is worth knowing, but never stop or change a prescribed medicine because of a lab value. Tell your doctor about every medicine and supplement you take, and let them weigh the trade-off. Your cholesterol tablet, for the record, is not the culprit: liver societies explicitly say statins are safe to use in people with fatty liver and high cholesterol.

What does "Grade 1 fatty liver with mild hepatomegaly" mean? It is the earliest ultrasound stage: the liver looks a touch brighter than the kidney but the vessels and diaphragm are still clearly visible, and the liver is slightly enlarged. There is no structural damage at this stage, and it is the most reversible point on the whole spectrum. Think of it as the liver waving a small flag, not sounding an alarm.

How to get tested so the numbers actually mean something

A liver workup is only as good as its preparation, and this is where small mistakes create big confusion. Fast for 9–12 hours before a lipid profile; water is fine, but no food, no tea or coffee, no juice, no chewing gum, no smoking, and skip the morning gym session. That fasting rule is our lab's protocol, and it overrides the non-fasting option some international guidelines allow. Fasting glucose needs at least an 8-hour overnight fast, while HbA1c needs no fasting at all.

Skip alcohol for at least 24–48 hours before liver tests. Alcohol bumps GGT and the transaminases, and testing too soon after drinking measures the party, not your baseline. Avoid a heavy workout for two to three days before the draw; hard exercise alone can push ALT and AST up enough to trigger a scare. Book a morning slot if you can, especially for fasting panels, and carry a list of every medicine and supplement you take, because the lab and your doctor both need it.

The night before your test

Do: finish dinner early enough to complete a 9–12 hour fast before a morning draw, and drink water normally through the evening and morning.

Don't: assume a "light" late-night snack is harmless, or have "just one drink" the evening before liver tests. Both show up on the report.

Medicines and supplements

Do: tell the phlebotomist and your doctor about every medicine, supplement, and herbal product you take, including doses and timing.

Don't: stop any prescribed medicine on your own to "clean up" a report. A manipulated report helps nobody, least of all you.

Reading your report

Do: read the whole pattern: ALT next to AST, the ratio, platelets, bilirubin, and the metabolic numbers together. Patterns diagnose; single values merely suggest.

Don't: panic over one mildly raised value, or decide its meaning from a single search result. An ALT of 68 with everything else clean is a follow-up, not a verdict.

Retesting

Do: repeat the tests after a few months of genuine lifestyle change, and keep the same lab if you can, so the trends are comparable.

Don't: retest the day after a wedding, a festival, or a heavy leg day. Retest your baseline, not your exceptions.

What to book, and what it costs to know

If your ultrasound says fatty liver, the efficient order is the full Liver Function Test panel rather than a lone SGPT. The panel bundles ALT, AST, bilirubin, ALP, GGT, albumin, and proteins in one draw, and we have a plain-spoken guide to reading the whole panel at our liver function test post. Add the lipid profile and HbA1c to cover the metabolic half, because the liver numbers without the metabolic numbers are half a story.

It also comes bundled: the Complete Liver Health Panel wraps the liver markers into broader screening, and the Liver Health Checkup - Basic is the lighter entry point. You can browse everything liver-related under our health packages, or start from the tests page if you are not sure what to book yet. We never print prices in articles because they change; the live price sits on each test page.

The practical bit: our phlebotomist can come to your home for the fasting draw, early morning before office hours, anywhere across Malad, Kandivali, Borivali, and Goregaon, free of charge. The needle prick is a sharp pinch that lasts a second, then the cotton ball taped to your arm, and the report is in your inbox by the next morning. The lab itself runs 24x7 from Malwani, Malad West. Bookings are one call away on 84250 40353.

Six things to carry away. Fatty liver is a metabolic condition with a new name, MASLD, and the blood tests track injury and risk while the scan sees fat. Normal enzymes never rule it out; up to three-quarters of people with fatty liver have normal LFTs at any given time. SGPT is the headline number, but the AST:ALT ratio, platelets, and the metabolic markers tell the fuller story, and FIB-4 turns four routine values into a fibrosis check. Preparation is half the test: 9–12 hours fasting for lipids, no alcohol for 24–48 hours, no hard workouts for two to three days. And early fatty liver reverses, 3–5% weight loss shrinks the fat, 7–10% calms the inflammation. The blood work is not there to scare you. It is there to show you, months before any symptom would, exactly where you stand and whether what you are doing is working.

References

AASLD multisociety consensus on MASLD nomenclature, 2023. Cleveland Clinic, Liver Function Tests. Mayo Clinic, liver function tests and diabetes testing information. CDC, Testing for Cholesterol. American Diabetes Association 2025 consensus report on MASLD screening in people with diabetes.